Tag: Cancer: Lung
AACR: Pembrolizumab Beneficial for Advanced Small Cell Lung Cancer
Antitumor activity promising; objective response rate 19.3 percent for patients with incurable, advanced SCLC
Radiomic Features May Predict Response to Chemo in NSCLC
Peritumoral, intratumoral radiomic features on baseline CT scans may predict chemo response
FDA OKs Tecentriq for Extensive-Stage Small Cell Lung Cancer
Drug now approved as first-line treatment to be used in combination with carboplatin and etoposide
New AI Model May Predict Cancerous Lung Nodules
Model relies on CT features, demographics, clinical data, and improves on current methods
Liquid Biopsy-Based Test IDs Biomarkers in Metastatic NSCLC
Test led to increase in number of patients with identified G7 biomarker, reduction in turnaround time
Intervention Can Reduce Racial Differences in Lung Cancer Care
Race-specific data, EHR warnings may decrease racial disparities in care for early-stage lung cancer
U.S. Agencies Probing Johnson & Johnson Over Asbestos in Talc
Company has faced lawsuits linking its body powders with ovarian cancer or mesothelioma
Complications Higher Than Expected for Invasive Lung Tests
Complication rates for invasive lung diagnostic procedures higher than those seen in clinical trials
Median Survival for Stage 4 ALK-Positive NSCLC Nearly 7 Years
Most patients in study received crizotinib; prognosis worse when more organs have tumors at diagnosis
Childhood Hodgkin Lymphoma Survivors at Risk for Later Cancers
Survivors have 14-fold increased risk for developing a solid subsequent malignant neoplasm
